ORMP Return on Tangible Equity | ORAMED PHARMACEUTICALS INC.

ORAMED PHARMACEUTICALS INC. (ORMP) Return on Tangible Equity

2026-06-30: Return Tang Equity 55.08%.
2026-03-31: Return Tang Equity 46.17%.
2025-12-31: Return Tang Equity 32.07%.
2025-09-30: Return Tang Equity 21.57%.

Complete source-backed return tang equity history.

Available history: 2008-08-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	55.08%
2026-03-31	46.17%
2025-12-31	32.07%
2025-09-30	21.57%
2025-06-30	-15.64%
2025-03-31	-20.05%
2024-12-31	-13.03%
2024-09-30	2.57%
2024-06-30	11.54%
2024-03-31	6.01%
2023-12-31	3.11%
2023-09-30	-10.97%
2023-06-30	-13.32%
2023-03-31	-19.56%
2022-12-31	-24.27%
2022-09-30	-23.67%
2022-06-30	-23.99%
2022-03-31	-20.91%
2021-11-30	-15.95%
2021-09-30	-19.70%
2021-08-31	-19.68%
2021-06-30	-21.81%
2021-05-31	-31.49%
2021-03-31	-29.54%
2021-02-28	-31.26%
2020-11-30	-51.53%
2020-08-31	-35.01%
2020-05-31	-102.44%
2020-02-29	-177.68%
2019-11-30	-123.54%
2019-08-31	-118.39%
2019-05-31	2.53%
2019-02-28	-31.09%
2018-11-30	-50.24%
2018-08-31	-40.91%
2018-05-31	-75.03%
2018-02-28	-49.36%
2017-11-30	-45.62%
2017-08-31	-54.48%
2017-05-31	-125.96%
2017-02-28	-98.45%
2016-11-30	-81.82%
2016-08-31	-74.00%
2016-05-31	-13.97%
2016-02-29	-24.18%
2015-11-30	-34.28%
2015-08-31	-29.13%
2015-05-31	-69.77%
2015-02-28	-51.34%
2014-11-30	-46.19%
2014-08-31	-48.93%
2014-05-31	33.05%
2014-02-28	17.91%
2013-11-30	55.67%
2013-08-31	52.05%
2013-05-31	-114.70%
2013-02-28	-77.45%
2012-11-30	-61.19%
2012-08-31	-88.51%
2012-05-31	-141.37%
2012-02-29	-74.20%
2011-11-30	-43.32%
2011-08-31	-41.94%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	32.07%
2024-12-31	-13.03%
2023-12-31	3.11%
2022-12-31	-24.08%
2021-08-31	-19.86%
2020-08-31	-35.01%
2019-08-31	-74.02%
2018-08-31	-40.91%
2017-08-31	-54.48%
2016-08-31	-41.86%
2015-08-31	-29.13%
2014-08-31	-27.39%
2013-08-31	52.05%
2012-08-31	-88.51%
2011-08-31	-41.94%
2010-08-31	-358.60%
2009-08-31	-100.52%
2008-08-31	-60.29%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Zentalis Pharmaceuticals, Inc. (ZNTL)	United States	$0.196B	-2.48
Nkarta, Inc. (NKTX)	United States	$0.205B	-1.73
Fortress Biotech, Inc. (FBIO)	United States	$0.188B	0.91
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
Foghorn Therapeutics Inc. (FHTX)	United States	$0.213B	-4.43
Organogenesis Holdings Inc. (ORGO)	United States	$0.182B	-3.70
Eledon Pharmaceuticals, Inc. (ELDN)	United States	$0.219B	-3.23
Whitehawk Therapeutics, Inc. (WHWK)	United States	$0.221B